Elicio Therapeutics Inc. (ELTX) — Cash Flow Quality Index
Elicio Therapeutics Inc. (ELTX) has a Cash Flow Quality Index of -0.96x as of December 2021. Operating cash flow of $-14.36 Million is below net income of $14.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Elicio Therapeutics Inc. balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Elicio Therapeutics Inc. Cash Flow Quality Index (2012–2013)
Historical Cash Flow Quality Index for Elicio Therapeutics Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ELTX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Elicio Therapeutics Inc. (2012–2013)
Year-by-year earnings quality comparison for Elicio Therapeutics Inc.. For live market cap and the full company financial profile, see ELTX company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2013 | 2.99x | $1.89 Million | $632.24K | ▼ -13.7% |
| 2012 | 3.47x | $1.07 Million | $307.30K | — |